To accelerate biomedical innovation

Foundation for Neglected Disease Research (FNDR) Bangalore and Blockchain For Impact (BFI) announced an impact-driven partnership under the BFI-Biome Virtual Network Program, aimed at advancing healthcare in India. BFI aims to allocate $300,000 to FNDR over three years, to support projects aimed at translating research into tangible healthcare solutions. 

FNDR, a not-for-profit R&D organisation known for its innovative and affordable solutions, is dedicated to discovering and developing drugs, diagnostics, and devices to combat infectious diseases with a high socio-economic impact, including tuberculosis, non-tuberculous mycobacterial diseases, malaria, neglected tropical diseases (Dengue, Leishmania, Rabies), serious bacterial infections, fungal infections, viral infections (Influenza, COVID-19), and antimicrobial resistance (AMR).

The announcement was made at an event in Bangalore, attended by Dr Shridhar Narayanan, Chairman and CEO, FNDR, Dr RK Shandil, Director and Chief Scientific Officer, FNDR, and Dr Pooja Agrawal, Program Director, BFI. This collaboration leverages the strengths of both organisations. By combining FNDR’s research expertise with BFI’s network, BFI aims to make a tangible difference in the Indian healthcare ecosystem.

Sandeep Nailwal, Founder and visionary behind BFI, expressed his delight at the announcement of FNDR as one of the infectious disease partners in the BFI-Biome Virtual Network. This collaboration integrates both upstream and deep science, creating an environment that drives innovation leading to transformative health solutions in India and the global south.

Dr Gaurav Singh, CEO, BFI, expressed his excitement about the network, stating, “We are delighted to have FNDR join our BFI-Biome Network. This synergy will undoubtedly expedite advancements in Indian biomedical research, ultimately contributing to the betterment of the healthcare ecosystem in India.”

Dr Pooja Agrawal, Program Director, BFI, emphasised the importance of the collaboration, stating, “Through this partnership, we hope to accelerate the development and delivery of life-saving treatments and interventions against infectious diseases and neglected tropical diseases that pose a significant burden on the developing world.”

Dr Satya Prakash Dash, Principal Advisor, BFI, stated, “The partnership with FNDR aligns with BFI’s vision of supporting deep biomedical innovation in India & we look forward to building a strong foundation of biomedical research & innovation.”

Dr Narayanan, stated, “The groundbreaking partnership with BFI will help accelerate the discovery and development of much-needed solutions for advancing therapeutic strategies against life-threatening neglected tropical diseases.”

Dr Shandil, Director and Chief Scientific Officer, FNDR, stated, “The partnership between FNDR and BFI is focussed on delivering novel and impactful solutions, be it drugs, diagnostics or devices, especially in the neglected tropical disease space. The combined efforts of both the organisations can deliver solutions with a high socio-economic impact.”